Pharmacogenomic Effect/ADR for Dexlansoprazole (DBSNPE006892)

Identifier
DBSNPE006892
Drug
Dexlansoprazole (DB05351)
Interacting Gene/Enzyme
Cytochrome P450 2C19
Gene Name
CYP2C19
UniProt ID
P33261
Defining Change(s)
557G>Crs140278421
991A>GNot Available
Allele Name
CYP2C19*22
Genotype(s)
Not Available
Type(s)
Effect Inferred
Groups
Non-functional CYP2C19
Description
Poor drug metabolizer.
References
  1. Dexilant® (dexlansoprazole) delayed-release capsules[package insert]. Deerfield, Illinois: Takeda Pharmaceuticals America, Inc.; 2016. [Link]